hematologic malagnancies
Conditions
Interventions
Group 1: Experimental intervention (intervention group): Wohle body vibration: 3x/ week on Galileo vibration plate
Group 2: Control intervention (control group): endurance training 3/week on a bicycle
Sponsors
Universitätsklinik Freiburg,Klinik für Innere Medizin ISchwerpunkt Hämatologie, Onkologie und Stammzelltransplantation
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: patients with hematological malignancies and an planned stationary stay of at least two weeks because of chemotherapy, signed informed consent.
Exclusion criteria
Exclusion criteria: Endoprosthesis in knee oder hip, other meta implant in lower extremities, fractures, acute arthritis, venous thrombosis, epilepsy, instable bone metastases, unknown back pain, acute slipped disc, myocardial infarction, Angina pectoris or heart disease (NYHA III-IV) in a time period of 6 months, arterial hypertension, cardial pacemaker, which is not treated adequately (in therapy >180mmHg systolic; >100mmHg diastolic), Thrombocytes = 10.000µl, hemoglobin < 8g/dl
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Performed exercise sessions in relation to planned exercise sessions of intervention group compared to control group [%], feasibility studxy | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. self created questionnaire about vibration tolerance [score] 2. Force plate (GKS 1000, Mittweida) [cm] (sway path of center of pressure [COP]) and timed-up-and-go-test [sec] (postural control and mobility) 3. EORTC QLQ-C30 (quality of life questionnaire) | — |
Countries
Germany
Contacts
Public ContactAntonia Pahl
Universitätsklinik FreiburgKlinik für Innere Medizin ISchwerpunkt Hämatologie, Onkologie und Stammzelltransplantation
Outcome results
None listed